Curiox

Singapore Founded: 2007 • Age: 19 yrs
Wall-less plates and washers are developed for automated cell-based assays.
Annual revenue $3.6M Latest available
Total funding $30.0M 4 rounds
Employees 23 Tracked headcount
Investors 9 Known backers
Products 4 Services tracked
Competitors 9 Brand Intelligence

About Curiox

Curiox is a company based in Singapore founded in 2007 by Leck Kwong Joo. Curiox has raised $30 million across 4 funding rounds from investors including KB Investment, HB Investment and QUAD Investment Management. The company has 23 employees as of December 31, 2024. Curiox offers products and services including Pluto Workstation, Pluto Code, Pluto ALPHA, and AUTO 1000 System. Curiox operates in a competitive market with competitors including Evosep, Ovizio, Pressure BioSciences, inveox and Annaida, among others.

  • Headquarter Singapore
  • Employees 23 as on 31 Dec, 2024
  • Founders Leck Kwong Joo
  • Stage Public
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Curiox Biosystems Co., Ltd.
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $3.56 M (USD)
    12.29
    as on Dec 31, 2025
  • Net Profit
    -$18.81 M (USD)
    -236.04
    as on Dec 31, 2025
  • EBITDA
    -$7.64 M (USD)
    -30.83
    as on Dec 31, 2024
  • Total Equity Funding
    $30 M (USD)

    in 4 rounds

  • Latest Funding Round
    $15 M (USD), Series C

    Mar 16, 2022

  • Investors
  • Employee Count
    23

    as on Dec 31, 2024

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of Curiox

Curiox is a publicly listed company on the KRX with ticker symbol 445680 in South Korea, operating in the Technology services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: KRX · Ticker: 445680 · Sector: Technology services · South Korea

Products & Services of Curiox

Curiox offers a comprehensive portfolio of products and services, including Pluto Workstation, Pluto Code, Pluto ALPHA, and AUTO 1000 System.

Product name locked
Category locked
Primary

Enables cell staining and washing for laboratory workflows.

Product name locked
Category locked
Locked

Automates high-throughput flow and mass cytometry processes.

Product name locked
Category locked
Locked

Improves safety and results in cell analysis applications.

Product name locked
Category locked
Locked

Accelerates sample preparation for cytometry workflows.

People of Curiox

Headcount 50-200
Employee Profiles 15
Board Members and Advisors 4
Employee Profiles
People
Hongtae Jung
EVP & CFO
People
Namyong Kim
CEO
People
Sungchul Park
Director of Management Planning
People
Xiao Yang
General Manager, Greater China

Unlock access to complete

Board Members and Advisors
people
Giok Lak Sim
Board Member
people
Aleum Lee
Board Member
people
Youngtae Hong
Board Member
people
Kok Hwee Sim
Board Member

Unlock access to complete

Funding Insights of Curiox

Curiox has successfully raised a total of $30M across 4 strategic funding rounds. The most recent funding activity was a Series C round of $15 million completed in March 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investors in Curiox

Curiox has secured backing from 9 investors, including venture fund and institutional investors. Prominent investors backing the company include KB Investment, HB Investment and QUAD Investment Management.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Venture capital fund investing in early-stage tech startups
Locked Locked Locked
-
Locked Locked Locked
Dayli Partners is focused on bio-healthcare and fintech investments.
Locked Locked Locked
Premium access

Investor details for Curiox

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Curiox

Investments
Premium access

Investment portfolio details for Curiox

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Curiox

Premium access

Detailed financials for Curiox

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Curiox Comparisons

Curiox Primary company
Description
Wall-less plates and washers are developed for automated cel...
Location
Singapore
Founded Year
2007
Annual Revenue
$3.56 M (USD)
Net Profit
-$18.81 M (USD)
EBITDA
-$7.64 M (USD)
Employees
23
As of 2024
Premium access

Peer comparison for Curiox

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Curiox

Curiox operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Evosep, Ovizio, Pressure BioSciences, inveox and Annaida, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Solutions for clinical proteomics sample preparation are developed.
Locked Locked Locked
Imaging systems and AI software for microscopes are developed.
Locked Locked Locked
Biomolecular reactions are controlled via pressure cycling technology.
Locked Locked Locked
Automated solutions for biopsy sample preparation in laboratories are provided.
Locked Locked Locked
Magnetic resonance sensors for microscopic studies are developed.
Premium access

Detailed competitors of Curiox

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Curiox

Premium access

Complete news archive for Curiox

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Curiox

Curiox was founded in 2007.

Curiox is headquartered in Singapore.

Curiox is a funded company, having raised a total of $30M across 4 funding rounds to date.

As of Dec 31, 2024, the latest employee count at Curiox is 23.

Annual revenue of Curiox is $3.56M as on Dec 31, 2025.

Curiox was established in 2007 as a spin-out from Singapores Agency for Science, Technology, and Research (ASTAR). Operations focus on bioinstrumentation, with wall-less plates and washers designed to automate miniaturized cell-based assays. DropArray technology is employed to reduce volumes to 5ul without major workflow adjustments. Products include the DropArray Microplate, HT200 Washing Station, and LT210 Washing Station, supporting research in cell analysis.

Curiox's top competitors include Ovizio, Evosep and inveox.

Curiox offers Pluto Workstation, Pluto Code, Pluto ALPHA, and AUTO 1000 System.

Yes, Curiox is publicly traded on KRX under the ticker symbol 445680.

Curiox has 9 investors. Key investors include KB Investment, HB Investment, QUAD Investment Management, Luha Private Equity, and Dayli Partners.

The ticker symbol of Curiox is 445680 on KRX.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available